As of 2024-12-14, the EV/EBITDA ratio of Rapt Therapeutics Inc (RAPT) is 0.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAPT's latest enterprise value is -6.09 mil USD. RAPT's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above RAPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-13 | 0.06 |
| 2024-12-12 | 0.02 |
| 2024-12-11 | -0.00 |
| 2024-12-10 | -0.00 |
| 2024-12-09 | -0.03 |
| 2024-12-06 | 0.01 |
| 2024-12-05 | 0.02 |
| 2024-12-04 | 0.01 |
| 2024-12-03 | -0.04 |
| 2024-12-02 | -0.02 |
| 2024-11-29 | -0.06 |
| 2024-11-27 | -0.05 |
| 2024-11-26 | -0.01 |
| 2024-11-25 | -0.01 |
| 2024-11-22 | 0.00 |
| 2024-11-21 | 0.01 |
| 2024-11-20 | 0.00 |
| 2024-11-19 | 0.00 |
| 2024-11-18 | -0.01 |
| 2024-11-15 | -0.01 |
| 2024-11-14 | -0.06 |
| 2024-11-13 | -0.16 |
| 2024-11-12 | -0.21 |
| 2024-11-11 | -0.22 |
| 2024-11-08 | -0.59 |
| 2024-11-07 | -0.65 |
| 2024-11-06 | -0.53 |
| 2024-11-05 | -0.44 |
| 2024-11-04 | -0.38 |
| 2024-11-01 | -0.37 |
| 2024-10-31 | -0.34 |
| 2024-10-30 | -0.36 |
| 2024-10-29 | -0.30 |
| 2024-10-28 | -0.27 |
| 2024-10-25 | -0.26 |
| 2024-10-24 | -0.22 |
| 2024-10-23 | -0.21 |
| 2024-10-22 | -0.23 |
| 2024-10-21 | -0.18 |
| 2024-10-18 | -0.23 |
| 2024-10-17 | -0.20 |
| 2024-10-16 | -0.22 |
| 2024-10-15 | -0.24 |
| 2024-10-14 | -0.27 |
| 2024-10-11 | -0.24 |
| 2024-10-10 | -0.19 |
| 2024-10-09 | -0.26 |
| 2024-10-08 | -0.26 |
| 2024-10-07 | -0.26 |
| 2024-10-04 | -0.30 |